← All organizations
First clinical trial
May 1, 2004Last known activity
Aug 17, 2016
Timeline
1990s
- Jan 1, 1994
Assisi Foundation— Founded
Drugs by trial phase (32 distinct, 9 trials)
Phase 2 (31 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Hematologic Neoplasms
- Histiocytosis
- Immunologic Deficiency Syndromes
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Myelomonocytic, Juvenile
- Lymphoma
- Myelodysplastic Syndromes
- Neoplasms
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Sarcoma, Myeloid
- Severe Combined Immunodeficiency
- X-Linked Combined Immunodeficiency Diseases
Recent trials (9)
- NCT01512888CollaboratorPhase 1/Phase 2Aug 17, 2016
- NCT01807611CollaboratorPhase 2May 16, 2013
- NCT01700946CollaboratorPhase 2Apr 15, 2013
- NCT01621477CollaboratorPhase 2Aug 1, 2012
- NCT01328496CollaboratorPhase 2Jun 15, 2011
- NCT00995137CollaboratorPhase 1Oct 1, 2009
- NCT00640796CollaboratorPhase 1Sep 1, 2008
- NCT00697671CollaboratorPhase 1Mar 1, 2007
- NCT00145626CollaboratorPhase 2May 1, 2004
Details
- Founded
- Memphis, TN, US Jan 1, 1994
- Last known activity
- Aug 17, 2016